Open label extension study of ADS-4101 in the patients with epilepsy
Phase of Trial: Phase III
Latest Information Update: 22 Mar 2018
Price : $35 *
At a glance
- Drugs Lacosamide (Primary)
- Indications Epilepsy
- Focus Therapeutic Use
- 22 Mar 2018 Patient gender is assumed.
- 22 Mar 2018 New trial record
- 15 Mar 2018 According to Adamas Pharmaceuticals Form 10-K, this trial is anticipated to begin in 2019.